Idiotype (Id) 16/6 marks a variable (V) region structure that occurs frequently in the human immunoglobulin repertoire. The basis of the Id has been traced to a germline heavy chain gene segment, V.18/2 (V.26). To pursue the molecular basis for the frequency of Id 16/6, we have analyzed polymerase chain reaction-generated C/z, C% and V.3 family V gene libraries derived from the circulating and tonsillar B cells of four normal individuals and from the B cells of two patients with active systemic lupus erythematosus (SLE). The frequency of V.18/2 in these libraries was compared with three control V. genes, V.56P1, V.21/28, and V.A57. Plaque lifts from C/z and C3' V. cDNA libraries were screened with gene-specific oligonucleotide probes. The frequency of V.18/2 ranged from 4 to 10% ofJ. + plaques (two to five times that of control V. genes). In four V.3 family-specific libraries derived from rearranged DNA, V.18/2 represented 19-33% of V.3 + plaques. Hybridizing V.18/2 plaques were 98-100% homologous to the germline V. gene; mutations when present were often in framework 3. Extensive variation was seen in the complementarity determining region 3 sequences of these rearranged V genes. The high frequency of V.18/2 expression in the B cell repertoire was confirmed by sequencing randomly picked J.+ plaques. In two patients with active SLE the frequency of use of V.18/2 was not greater than that observed in normal subjects. These results show that V.18/2 is overrepresented in the B cell repertoire of normal subjects and suggest that the immune repertoire may be dominated by relatively few V genes. I d 16/6, an idiotypic marker identified originally in a human IgM anti-DNA mAb, has been found in the serum of most patients with active SLE, in the renal and skin lesion of lupus, in the serum of patients with certain bacterial infections or autoimmune diseases other than SLE, in 10% of monoclonal gammopathies, and in normal serum. The Id occurs in a wide spectrum of racial and ethnic groups, and B cells from cord blood, children, and adults can all produce it (reviewed in reference 1). Id 16/6 thus marks a V region structure that occurs in high frequency in the human Ig repertoire. The basis of the Id has been traced to a germline heavy chain gene segment, V.18/2 (also called V.26 and V.30p1), a member of the V.3 family (2). V.18/2 has been localized to a 500-kb region in the 3' end of the V. locus (3). The germline gene has a unique defining sequence in the 5' region of its CDR2, and an oligonucleotide probe corresponding to this region was shown to hybridize to a single 2.0-kb band in genomic DNA (4). This probe has identified V.18/2 in the genomic DNA of >98% of tested subjects. Moreover, all genomic clones identified by moderate stringency hybridization with the CDR2 probe had an identical sequence (5).
I d 16/6, an idiotypic marker identified originally in a human
IgM anti-DNA mAb, has been found in the serum of most patients with active SLE, in the renal and skin lesion of lupus, in the serum of patients with certain bacterial infections or autoimmune diseases other than SLE, in 10% of monoclonal gammopathies, and in normal serum. The Id occurs in a wide spectrum of racial and ethnic groups, and B cells from cord blood, children, and adults can all produce it (reviewed in reference 1). Id 16/6 thus marks a V region structure that occurs in high frequency in the human Ig repertoire. The basis of the Id has been traced to a germline heavy chain gene segment, V.18/2 (also called V. 26 and V.30p1), a member of the V.3 family (2). V.18/2 has been localized to a 500-kb region in the 3' end of the V. locus (3) . The germline gene has a unique defining sequence in the 5' region of its CDR2, and an oligonucleotide probe corresponding to this region was shown to hybridize to a single 2.0-kb band in genomic DNA (4) . This probe has identified V.18/2 in the genomic DNA of >98% of tested subjects. Moreover, all genomic clones identified by moderate stringency hybridization with the CDR2 probe had an identical sequence (5) .
V.18/2 is thus highly conserved and its Ig product is found in a variety of normal and pathological conditions. To test the possibility that V.18/2 is overrepresented in B cell populations, we studied the frequency of this gene in the expressed V. gene repertoire of two normal individuals. To survey the expressed human V. gene repertoire, we generated Ig cDNA libraries from B cells obtained from normal adults in a two-step PCR procedure without B cell selection or manipulation. V gene primers are not used in this procedure, thus allowing random amplification of all V. families (6) . The frequency of V.18/2 use was also determined in V.3 family-specific libraries generated by the PCR of rearranged Ig DNA from the peripheral blood of a normal adult, a tonsil, and from the blood of two patients with SLE. The frequency of V.18/2 in these libraries was determined by hybridization to plaque lifts with the gene-specific probe and confirmed by sequence analysis. The results with V.18/2 were compared with two other V.3 family genes, V.56p1 and V.A57, and with V.21/28 (a member of the V.1 family). The results showed a prominence of peripheral blood B cells that had rearranged V.18/2, and suggest that the V. gene repertoire of human B cells is strongly biased.
Materials and Methods
Ig eDNA Libraries. PBMC isolated from two normal adult donors (Caucasian and Asian) by centrifugation through FicollHypaque were washed twice in PBS. No further manipulation was carried out before extraction of mRNA over an oligo(DT) column (Invitrogen, San Diego, CA). Double-stranded (ds)cDNA was synthesized from mRNA according to the method of Gubler and Hoffman (7) and blunt ended with T4 DNA polymerase. The primer for cDNA synthesis was complementary to a sequence within the C/~1 or C3'1 regions. Two steps of PCR amplification were performed, as described previously (6) . The first step was primed by oligonucleotide primers attached to the ends of the ds cDNA. The products were ligated into M13mp19 replicative (RF) DNA. A second amplification used a downstream nested C/x primer and an upstream primer within the M13 vector DNA. The second PCR products were again ligated to M13RF DNA. This ligation mixture was transformed into DH5c~ bacteria to form the cDNA library for screening. The M13 plaques were lifted onto Genescreen membranes (DuPont-New England Nuclear, Boston, MA), and the membranes were prehybridized, hybridized, and washed at high stringency as described by Treppichio and Barrett (8) . Radiolabeled probes were stripped from the membranes before rehybridization. Plaque lifts were screened by hybridization to a degenerate J. gene oligonucleotide probe. The J. probe was end-labehd by T4 polynucleotide kinase and 3,-[32P] according to Manniatis et al. (9) . Oligonucleotide probes (Fig. 1) complementary to the conserved framework 3 (Fr3) 1 regions of the V.1 and V.3 families and to the CDK regions of the individual V. genes (V.18/2, V.21/28, V.56pl, and V.A57) were synthesized (Oligos etc. Inc., Wilsonville, OR), and these overlapping oligonucleotides were labeled by filling in of the ends with the Klenow fragment of DNA polymerase 1 and c~-[nP]deoxynucleoside triphosphates. Unincorporated nucleotides were removed on NENSORB columns (DuPontNew England Nuclear). For more detailed analysis hybridizing plaques were picked for sequencing by chain termination with dideoxynucleoside triphosphates and sequenase (U.S. Biochemical Co., Cleveland, OH). The resulting sequences were compared with published sequences in the human GenBank database with the FASTA program of the GCG software package (10) .
I,',3 Family-specific Libraries. DNA was extracted from lymphoid cells by proteolysis, phenol/chloroform extraction, and precipitated in ethanol. PCR amplification was carried out using a V.3 leader sequence primer (GCTCTAGAACCATGGAGTTTGGGC-TGAG) and a consensus J. primer (GGGAATTCTGAGGAGACG-GTGACCAGGGT). The primers contained XbaI and EcoRI restriction sites to facilitate cloning. The conditions were a 5-min denaturation at 98~ followed by 94~ for 1 rain, 55~ for 1.5 rain, and 72~ for 1.5 min for 40 cycles with a 10-min extension at 72~ to finish. The resulting band was cut from low meltingtemperature agarose gel. Transformation into DHScff' Escherichia coli was performed, and plaque lifts were screened as described above.
Results
Specificity of Oligonucleotide Probes. The frequency of hybridization of V,18/2 and control probes was determined in 1 Abbreviation used in this paper: Fr3, framework 3.
3 ' GACACTTATAAAACAT ~ ' Figure 1 . Oligonucleotide probes used to screen libraries. Labeling was performed using a fill-in reaction.
the PCtL-generated Ig-specific libraries. Controls included: V.56pl, a VH3 family member found initially in fetal liver B cells (11); V.21/28, a germline V.1 family member found in autoantibodies (12); and V.A57, which is most likely a somatically mutated variant of V,18/2 (4). The specificity of the oligonucleotide probes for the V.18/2 and V.21/28 gene segments has been demonstrated previously (4) . These experiments showed that an oligonucleotide probe complementary to the 5' end of the CDR2 of V.18/2 hybridized to a single 2.0-kb band on a Southern blot of digested genomic DNA. Sequence analysis has confirmed that hybridization identifies a single germline V. gene (4) . The present experiments confirmed the specificity of the V,18/2 probe, which at high stringency identified only plaques with 97-100% homology to V~18/2 (see below). Hybridization with a combination of probes, identifying both the CDR1 and CDR2 of V.21/28, had a similar high specificity (D. R.ubinstein, unpublished data). The oligonucleotide probes for V.56p1 and VHA57 were complementary to their 5' CDR2 regions. Our V. oligonucleotide overlapped two previously described oligonucleotide probes, M10 (13) and H61 (14) . At high stringency both M10 and H61 identify the two bands on TaqI-digested DNA that contain the V.56pl germline gene (hv3005) and the highly related GLSJ2 germline gene (13, 14) . This area also shares identity with the closely related yet independent germline gene V.1.9III (13) . In fact, in our hands, the V.56pl oligonucleotide probe, when hybridized at moderate stringency (10~ below the Tm) to a (40) 14 (5) 7 ( with the V818/2-, V.21/28-, Va56pl-, and V.A57-specific oligonucleotides. Differences between the two individuals were noted (Table 1) ; the V.18/2 probe hybridized to 10% ofJ. + plaques in A/~ but only to 5% of plaques in T/~ ( to-silent ratio of 1.3. Although PCR error may also introduce mutation, our previous work indicated that no more than 1 base in 300 is likely to be misincorporated (15) . In 7 of 11 sequenced V818/2 genes, 100% identity to known D gene segments could be demonstrated over 9-22 bases in length (Fig. 5) . The D gene families DXP (five clones) and DLR (three clones) accounted for 8 of the 11 sequenced clones, a finding that reflects the overrepresentation of these gene families in normal subjects (15) (16) (17) . The J.4 gene is also overrepresented in the normal repertoire (15) (16) (17) and was used by 7 of the 11 V.18/2 clones described here.
V,,18/2 Is Found at High Frequency in VH3-specific Libraries.
In addition to the three C# libraries just discussed, VH3-specific libraries were generated from the lymphocyte DNA of one adult (AKS) and from a tonsillectomy sample (VAR). As seen in Table 2 , 19 and 28% of all V.3 + plaques in the two libraries hybridized to the Va18/2 CDR2 probe. The V.56P1 probe hybridized to 15% of the V.3 plaques in each library. Randomly sequenced plaques demonstrated that these libraries consisted of independent clones. 12 plaques picked at random from AKS were sequenced through CDR1 (Table 3) . 3 of the 12 shared 97.4, 99, and 99.6% sequence identity with V.18/2. Three (ks.5, ks.6, ks.17) shared >98% homology with a V.3 family member (N54P3) found in cord blood (18) , two clones (ks.9, ks.19) shared >97% with the fetal cDNA clone M26, and 1 of the 12 (ks.16) had 98% identity with V.56pl. 10 of 12 rearranged VH genes found in adult B ceils appear to derive from the so-called "fetal repertoire" of V. genes.
VH18/2 in SLE. The V.18/2 heavy chain is the major determinant of Id 16/6 (2). Levels of this Id fluctuate with disease activity in SLE and can be detected in the characteristic skin and renal lesions of this disease (19, 20) . We therefore predicted that, at least in some patients with active disease, V.18/2 would be found at a frequency higher than that observed in normal adults. To test this hypothesis, DNA extracted from the PBLs of two SLE patients with high-titer anti-DNA antibodies (LG and JAV) was PCR amplified with V.3-specific primers, and packaged in M13 as described above. Hybridization analysis revealed that in patient JAV 20% of V.3 clones hybridized to V.18/2, and 6% of V.3 clones to V.56P1, numbers consistent with those found in normal individuals (Table 2) . In patient LG, however, no V.18/2 was detected on hybridization. Indeed, analysis of this patient's serum failed to detect any Id 16/6. Granulocyte DNA from patient LG was amplified with a V.3 Fr3 and a Va3 leader primer. A Southern transfer of the product hybridized at high stringency to the V.18/2 5' CDR.2 probe, a finding that implies that this patient has a germline copy of V.18/2 that does not appear in the peripheral B cell population.
V,18/2 in IgG-specific Libraries. As the pathogenic autoantibodies in SLE are high-titer, high-affinity IgG antibodies, we were interested in the frequency of use and mutation of V.18/2 in the IgG populations of normal donors. An IgGspecific cDNA library was amplified to include all V. families (A3'). Hybridization results from this library revealed 45 V.18/2 § plaques (7% of V.3 and 4% of all J.) ( Table 1) . Four V.18/2 hybridizing plaques were sequenced and were identical in CDR3. As this may invalidate the hybridization data, randomly picked J.+ plaques were also sequenced. 3 of 30 randomly picked plaques with independent CDR3 segments were 96, 99, and 100% homologous to V.18/2 at least through CDR1 (not shown). The frequency of V.18/2 expression, as determined by random sequencing, is therefore at least 7% of JH in this Cy library.
Discussion
Although 100-200 bands can be seen on Southern blot analysis of human DNA hybridized with V. family-specific probes, the exact number of functional VH genes available for rearrangement is unknown (21) . The finding of recurrent individual V. genes in B cell malignancies (22) , fetal liver B cells (11, 23) , and in autoantibodies produced by adults (24) suggests that some individual V. gene segments are prone to preferential selection, or alternatively that the number of VH genes available for use in mature V.DJ recombinations may be lower than expected (25) .
The germline gene V.18/2 is a member of the largest V~ family (VH3) and is identical to V.26, which was originally identified on the basis of its homology to a murine V. gene probe (26) . Subsequently, V.26 has been identified with surprising frequency in fetal liver B cells (10, 21) , anti-DNA and other autoantibodies (27, 28) , B cell malignancies (29) , and in the antibody response of normal individuals to immunization with hemophilus B (30, 31) . However, since the representation of V.18/2 in the repertoire of normal B cells was hitherto unknown, interpretation of the overrepresentation of this gene in pathologic conditions was difficult. 415 Stewart et al.
The V.18/2 gene segment is demonstrated here to be overrepresented in the unstimulated peripheral blood B cells of normal individuals, with 4-10% of all J.+ plaques and 12-33% of all V.3 + plaques hybridizing to a V.18/2-specific probe (Fig. 6) . Thus, although the V.3 family is estimated to contain at least 25 members, a single VH gene accounts for up to 25% of all expressed members of this family. Moreover, this value of 25% is likely to be an underestimate of the true frequency of V.18/2 because the high-stringency conditions used to identify the gene would miss mutant variants in CDR2. The frequency of rearrangement of another recurring V.3 family member, studied for comparative purposes (V.56pl), was 2% ofJ. § and 6-15% of VH3 + plaques. As a further comparison, V.21/28, a member of the large V.1 family, also represented 2% of all J.+ plaques (6-7% of all V.1 plaques). Thus, although V.18/2 predominates, all of the studied V. genes are rearranged at a higher than expected frequency, assuming a total of at least 100 functional V. genes.
Examples of other V gene sequences identified at high frequency in normal individuals include the V.4 family member V.4.21 (31), the V.1 family member V.51pl (32) the VK gene humkv. 3.25 (33, 34) , the D gene segment Dnl (15) (16) (17) , and the J. gene J.4 (15) (16) (17) . V.51pl and Vh4. 21 have been identified by their respective idiotypic markers in 2 and 3% of tonsillar B cells, and V.4.21 in 10% of bone marrow B cells (31, 32) . V.6 and the recently described V.7 gene segment have been found at high frequency in fetal (11, 23) and cord blood B cells (18) , and in up to 6% of all circulating B cells in one normal adult (15) . It is likely that other examples of V. genes found at high frequency in normal individuals remain to be identified. By extension, it is therefore possible that the expressed repertoire of human V genes will ultimately prove to represent only a fraction of the potentially available germline.
A number of reasons have been proposed for the overrepresentation of certain germline V genes in fetal liver, autoantibodies, B cell malignancy, and now in normal individuals. These relate to chromosomal position (35) , the number of gene copies in the germline (36) , preferential rearrangement on the grounds of unique recombinase accessibility or recognition sequences, the presence of gene-specific promotor enhancer sequences (37) , and preferential selection on the basis of antigen binding or Id specificities (38) .
A gene product may be found at higher than predicted frequency if more than one copy exists in the germline. In fact, there are probably two copies of V.18/2 in the germline (5) , and this may partially explain its preponderance in the repertoire. However, as our V.56pl probe recognizes at least two highly related yet independent germline V. genes (13, 14) , the predominance of V.18/2 over V.56p1 (and related genes) in this study implicates factors other than multiple copies.
V.18/2 is highly conserved and its coding region is not polymorphic (5) . This suggests that V.18/2 may be preferentially selected because of the antigen binding or idiotypic properties of its protein product. V.18/2 has a sequence in Fr3 that is highly conserved between species and within the V.3 family, but that differs from other families (37) . This sequence may encode a unique antigen binding site in the protein product not related to the classical CDR-related binding sites. Of interest, the consensus sequence from all known V.3 family members is identical to the V.18/2 sequence in this region. It is therefore notable that 9 of 11 V.18/2 amino acid substitutions found in this study were in Fr3 (Figs. 4 and 5) . Perhaps V,18/2 is selected on the basis of this highly conserved potential antigen binding site. Precedence for this hypothesis has been demonstrated in mice in which clonal persistence orB lyrnphocytes in normal animals is determined by V. family-dependent selection (39) .
Since Id16/6 is abundant in the serum of some patients with active SLE and its levels fluctuate with disease activity, we expected to find an excess of V.18/2 plaques in some patients with active SLE. In a VH3 family library amplified from the DNA of a patient (JAV) with active lupus, V.18/2 was found to be rearranged in 20% of V.3 + clones, a frequency similar to that of normal individuals. In a second patient (LG), a patient without detectable Id in the serum, no V.18/2 was identified by hybridization. By PCR analysis this patient appears to have a copy of V.18/2 in the germline, and the absence of rearranged VH18/2 in this patient remains unexplained.
It therefore appears, at least from these limited studies, that a difference in the frequency of use of V.18/2 cannot explain the elevated levels of Id 16/6 in patients with active SLE. Our observation could be explained if other V. genes contribute to the Id (2), if activation of normally quiescent B cells bearing an 18/2 rearrangement results in the release of the Id into the serum, or if plasma cells producing Id 16/6 are sequestered from the circulation.
A possibility not previously considered is that the number of germline V. genes used in rearrangements is far lower than supposed. Such a limitation in diversity has been demonstrated in other species, such as the chicken and rabbit, which both generate diversity using an extremely restricted set of V. genes (40, 41) . The chicken uses only one VH and one VX gene. Indeed, all other VX genes in the germline of the species are pseudogenes, portions of which are subsequently used in gene conversion events to generate antibody diversity. In the rabbit, only one of many functional V. genes is used. This gene (V.1), which is the most 3' V. gene, generates diversity by a combination of somatic mutation and gene conversion. While gene conversion events are probable in humans their presence has yet to be conclusively documented (16) .
The majority of the C# VH18/2 clones we sequenced showed little mutation, even in CDR3, suggesting that the population of IgM + B cells bearing VH18/2 rearrangements may form part of the naive immune repertoire. Unmutated VH18/2 was also found in a C3' library. Taken together with the demonstration that V.18/2 can encode the heavy chains of anti-DNA antibodies, this finding suggests that germline genes capable of forming naturally occurring autoantibodies are not deleted from the IgG population of B cells in normal individuals.
Our results suggest that a significant fraction of the human Ig repertoire originates from a preimmune repertoire that is dominated by relatively few V genes. In this regard the remarkable polyspecifidty of antibodies encoded by germline V genes may be important. A limited number of polyreactive clones could form the substrate from which a diverse repertoire arises after clonal selection (24) .
The recurrent presence of individual germline VH genes can now be extended from the restricted B cell populations of the fetal repertoire, autoantibodies, and B cell malignancies to the expressed V gene repertoire of normal adults. We postulate that only a fraction of available germline V genes are used recurrently in the expressed repertoire, and that polyspecificity of naturally occurring antibodies in combination with CDR3 and somatic mutation compensate for the restriction to antibody diversity. The mechanisms by which preferential use of an individual V. gene arise remain speculative and deserve further investigation.
